Cartesian Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $884k | 87k | 10.22 |
| 2025-06-30 | $1.4M | 134k | 10.39 |
| 2025-03-31 | $1.9M | 147k | 13.18 |
| 2024-12-31 | $5.6M | 315k | 17.91 |
| 2024-09-30 | $5.8M | 376k | 15.31 |